Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ivana Rizzuto

Showing results (11-20 of 16) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 16 results.
The Cochrane Database of Systematic Reviews|March 4, 2021
Vascular endothelial growth factor (VEGF) targeting therapy for persistent, recurrent, or metastatic cervical cancerYunhai Chuai, Ivana Rizzuto, Xia Zhang, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|February 4, 2015
Risk of Ovarian Cancer Relapse score: a prognostic algorithm to predict relapse following treatment for advanced ovarian cancerIvana Rizzuto, Chara Stavraka, Jayanta Chatterjee, et al.
British Journal of Cancer|September 13, 2018
Anti-tumour activity of a first-in-class agent NUC-1031 in patients with advanced cancer: results of a phase I studySarah P Blagden, Ivana Rizzuto, Puvan Suppiah, et al.
British Journal of Cancer|April 18, 2019
A phase Ib dose-finding, pharmacokinetic study of the focal adhesion kinase inhibitor GSK2256098 and trametinib in patients with advanced solid tumoursGabriel Mak, Jean-Charles Soria, Sarah P Blagden, et al.
The Lancet. Oncology|October 22, 2013
The sex hormone system in carriers of BRCA1/2 mutations: a case-control studyMartin Widschwendter, Adam N Rosenthal, Sue Philpott, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 28, 2017
Evidence of Stage Shift in Women Diagnosed With Ovarian Cancer During Phase II of the United Kingdom Familial Ovarian Cancer Screening StudyAdam N Rosenthal, Lindsay S M Fraser, Susan Philpott, et al.
Pageof 2

Showing results (11-20 of 16) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 16 results.
The Cochrane Database of Systematic Reviews|March 4, 2021
Vascular endothelial growth factor (VEGF) targeting therapy for persistent, recurrent, or metastatic cervical cancerYunhai Chuai, Ivana Rizzuto, Xia Zhang, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|February 4, 2015
Risk of Ovarian Cancer Relapse score: a prognostic algorithm to predict relapse following treatment for advanced ovarian cancerIvana Rizzuto, Chara Stavraka, Jayanta Chatterjee, et al.
British Journal of Cancer|September 13, 2018
Anti-tumour activity of a first-in-class agent NUC-1031 in patients with advanced cancer: results of a phase I studySarah P Blagden, Ivana Rizzuto, Puvan Suppiah, et al.
British Journal of Cancer|April 18, 2019
A phase Ib dose-finding, pharmacokinetic study of the focal adhesion kinase inhibitor GSK2256098 and trametinib in patients with advanced solid tumoursGabriel Mak, Jean-Charles Soria, Sarah P Blagden, et al.
The Lancet. Oncology|October 22, 2013
The sex hormone system in carriers of BRCA1/2 mutations: a case-control studyMartin Widschwendter, Adam N Rosenthal, Sue Philpott, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 28, 2017
Evidence of Stage Shift in Women Diagnosed With Ovarian Cancer During Phase II of the United Kingdom Familial Ovarian Cancer Screening StudyAdam N Rosenthal, Lindsay S M Fraser, Susan Philpott, et al.
Pageof 2